Anti-drug antibody formation induced by recombinant activated FVII analogue (vatreptacog alfa) - results from the phase 3 adept (TM) 2 trial in haemophilia patients with inhibitors
JOURNAL OF THROMBOSIS AND HAEMOSTASIS（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要